AVR/I/SSAPDB: a Comprehensive & Specialised Knowledgebase of Antimicrobial Peptides to Combat VRSA, VISA, and VSSA

Overview

Journal World J Microbiol Biotechnol

Publisher Springer

Specialties Biotechnology
Microbiology

Date 2024 Oct 14

PMID 39402285

Authors

Rajat Kumar Mondal

Debayan Karmakar

Oshin Pal

Sintu Kumar Samanta

Affiliations

Soon will be listed here.

Abstract

The rise of multi-drug resistant (MDR) bacteria, especially strains of Staphylococcus aureus like Vancomycin-resistant S. aureus (VRSA), Vancomycin-intermediate S. aureus (VISA), and Vancomycin-susceptible S. aureus (VSSA), poses a severe threat to global health. This situation underscores the urgent need for novel antimicrobial agents to combat these resistant strains effectively. Here, we are introducing the Anti-Vancomycin-Resistant/Intermediate/Susceptible Staphylococcus aureus Peptide Database (AVR/I/SSAPDB), a manually curated comprehensive and specialised knowledgebase dedicated to antimicrobial peptides (AMPs) that target VRSA, VISA, and VSSA with clinical and non-clinical significance. Our database sources data from PubMed, cataloging 491 experimentally validated AMPs with detailed annotations on peptides, activity, and cross-references to external databases like PubMed, UniProt, PDB, and DrugBank. AVR/I/SSAPDB offers a user-friendly interface with simple to advanced and list-based search capabilities, enabling researchers to explore AMPs against VRSA, VISA, and VSSA. We are hoping that this resource will be helpful to the scientific community in developing targeted peptide-based therapeutics, providing a crucial tool for combating VRSA, VISA, and VSSA, and addressing a major public health concern. AVR/I/SSAPDB is freely accessible via any web-browser at URL: https://bblserver.org.in/avrissa/ .

References

Appelbaum P . The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2006; 12 Suppl 1:16-23. DOI: 10.1111/j.1469-0691.2006.01344.x. View

Bedard F, Fliss I, Biron E . Structure-Activity Relationships of the Bacteriocin Bactofencin A and Its Interaction with the Bacterial Membrane. ACS Infect Dis. 2018; 5(2):199-207. DOI: 10.1021/acsinfecdis.8b00204. View

Charles P, Ward P, Johnson P, Howden B, Grayson M . Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis. 2004; 38(3):448-51. DOI: 10.1086/381093. View

Chen H, Liu Y, Sun W, Chen M, Wang H . The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC. Diagn Microbiol Infect Dis. 2011; 71(3):301-3. DOI: 10.1016/j.diagmicrobio.2011.06.010. View

Cong Y, Yang S, Rao X . Vancomycin resistant infections: A review of case updating and clinical features. J Adv Res. 2020; 21:169-176. PMC: 7015472. DOI: 10.1016/j.jare.2019.10.005. View

Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K . Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother. 2000; 44(9):2276-85. PMC: 90058. DOI: 10.1128/AAC.44.9.2276-2285.2000. View

Culp E, Waglechner N, Wang W, Fiebig-Comyn A, Hsu Y, Koteva K . Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling. Nature. 2020; 578(7796):582-587. DOI: 10.1038/s41586-020-1990-9. View

Di Luca M, Maccari G, Maisetta G, Batoni G . BaAMPs: the database of biofilm-active antimicrobial peptides. Biofouling. 2015; 31(2):193-9. DOI: 10.1080/08927014.2015.1021340. View

Fan Z, Cao L, He Y, Hu J, Di Z, Wu Y . Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatus. Antimicrob Agents Chemother. 2011; 55(11):5220-9. PMC: 3195061. DOI: 10.1128/AAC.00369-11. View

10.

Francia M, Clewell D . Transfer origins in the conjugative Enterococcus faecalis plasmids pAD1 and pAM373: identification of the pAD1 nic site, a specific relaxase and a possible TraG-like protein. Mol Microbiol. 2002; 45(2):375-95. DOI: 10.1046/j.1365-2958.2002.03007.x. View

11.

Gardete S, Aires-de-Sousa M, Faustino A, Ludovice A, de Lencastre H . Identification of the first vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolate from a hospital in Portugal. Microb Drug Resist. 2008; 14(1):1-6. DOI: 10.1089/mdr.2008.0816. View

12.

Gawde U, Chakraborty S, Waghu F, Barai R, Khanderkar A, Indraguru R . CAMPR4: a database of natural and synthetic antimicrobial peptides. Nucleic Acids Res. 2022; 51(D1):D377-D383. PMC: 9825550. DOI: 10.1093/nar/gkac933. View

13.

Haley R, Hightower A, Khabbaz R, Thornsberry C, Martone W, Allen J . The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med. 1982; 97(3):297-308. DOI: 10.7326/0003-4819-97-3-297. View

14.

Hammami R, Hamida J, Vergoten G, Fliss I . PhytAMP: a database dedicated to antimicrobial plant peptides. Nucleic Acids Res. 2008; 37(Database issue):D963-8. PMC: 2686510. DOI: 10.1093/nar/gkn655. View

15.

Hernandez-Aristizabal I, Ocampo-Ibanez I . Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant Strains: Classification, Structures, and Mechanisms of Action. Int J Mol Sci. 2021; 22(15). PMC: 8347216. DOI: 10.3390/ijms22157927. View

16.

Hiramatsu K, Hanaki H, Ino T, YABUTA K, Oguri T, Tenover F . Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997; 40(1):135-6. DOI: 10.1093/jac/40.1.135. View

17.

Howden B, McEvoy C, Allen D, Chua K, Gao W, Harrison P . Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog. 2011; 7(11):e1002359. PMC: 3213104. DOI: 10.1371/journal.ppat.1002359. View

18.

Jhong J, Yao L, Pang Y, Li Z, Chung C, Wang R . dbAMP 2.0: updated resource for antimicrobial peptides with an enhanced scanning method for genomic and proteomic data. Nucleic Acids Res. 2021; 50(D1):D460-D470. PMC: 8690246. DOI: 10.1093/nar/gkab1080. View

19.

Jin Y, Yu X, Zhang S, Kong X, Chen W, Luo Q . Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive Strains. Front Microbiol. 2020; 11:596942. PMC: 7661696. DOI: 10.3389/fmicb.2020.596942. View

20.

Katayama Y, Murakami-Kuroda H, Cui L, Hiramatsu K . Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem. Antimicrob Agents Chemother. 2009; 53(8):3190-6. PMC: 2715608. DOI: 10.1128/AAC.00834-08. View